Prescription drug identification by imprint code
Pro Research Analysisby 
Searched over 200M research papers
Prescription Drug Identification by Imprint Code: System Overview
Prescription drug identification using imprint codes has become a critical tool for healthcare professionals, poison centers, and the public to quickly and accurately identify unknown tablets and capsules. Imprint codes typically consist of letters, numbers, or symbols stamped directly onto solid oral dosage forms, such as tablets and capsules, to distinguish them from one another and link them to specific manufacturers and drug products Robertson1985Marder2001A—General2012+1 MORE.
History and Regulatory Requirements for Drug Imprint Codes
The use of imprint codes began in the late 1960s, with pharmaceutical companies like Eli Lilly introducing systems that allowed for rapid identification of medications. By the late 1970s, over 90% of manufacturers were imprinting their products, and federal regulations eventually mandated imprints on all prescription and over-the-counter drugs Robertson1985Marder2001A—General2012+2 MORE. The FDA encourages the use of alphanumeric codes, as these are more effective for identification than symbols or logos alone .
Effectiveness and Limitations of Imprint Code Systems
Imprint codes have significantly improved the speed and accuracy of drug identification. Early field tests showed that identification could be achieved with over 98% accuracy in less than 12 seconds when using a standardized alphanumeric system . However, the continued use of symbols, logotypes, and trademarks as part of the code has limited the effectiveness of automated recognition systems and made some identifications more difficult Marder2001Vasudevan1996A—General2012.
Studies have shown that healthcare professionals' ability to identify drugs by imprint code varies widely. For example, pharmacists and poison center specialists correctly identified manufacturers 55% of the time, while nurses and medical students had a 35% success rate. None of the groups approached the ideal of 95% accuracy, indicating that current imprinting practices do not always allow for rapid and reliable identification Vasudevan1996Hatton2006. The use of multiple commercial resources can improve identification rates to over 95%, but this is not always practical in everyday clinical settings .
Challenges in Drug Identification by Imprint Code
Several challenges persist in the use of imprint codes for drug identification:
- Non-standardized Codes: The inclusion of symbols and logos, rather than exclusively alphanumeric codes, complicates both manual and automated identification Marder2001Vasudevan1996A—General2012.
- Incomplete Listings: Not all imprint codes are consistently listed in reference materials, leading to identification failures .
- User Awareness and Access: Many healthcare professionals are either unaware of or unable to effectively use available identification resources, reducing the system's overall effectiveness .
- Physical Changes: Changes in color, shape, or size of tablets over time can further hinder identification based on physical characteristics alone .
Technological Advances and Future Directions
The development of electronic databases and online resources has made it easier to search for imprint codes and identify unknown medications. Some systems now provide graphics of logos and allow for public and professional access via websites . Proposals have been made to further standardize imprint codes and eliminate the use of symbols, which would enable more effective automated and web-based identification systems Marder2001Muno2000.
Conclusion
Imprint codes have greatly enhanced the ability to identify prescription drugs, improving patient safety and supporting healthcare professionals in various settings. However, the system's effectiveness is limited by non-standardized codes, incomplete listings, and inconsistent user access to resources. Continued efforts to standardize imprint codes and expand electronic identification tools are essential for maximizing the utility and reliability of prescription drug identification by imprint code Marder2001Vasudevan1996A—General2012+2 MORE.
Sources and full results
Most relevant research papers on this topic
Decoding "drug imprints" at the millennium: a proposal to increase accuracy and reduce costs.
Eliminating symbols and logotypes from drug imprints could increase accuracy and reduce costs for poison centers, potentially saving $25 million/year.
Avoiding medication mixups. Identifiable imprint codes.
Current imprinting on solid medication forms fails to accurately identify manufacturers, requiring a voluntary collaborative effort by the pharmaceutical industry to improve identification.
PART 207—REGISTRATION OF PRO- DUCERS OF DRUGS AND LISTING OF DRUGS IN COMMERCIAL DIS- TRIBUTION
Drug products must bear an imprint identifying the manufacturer and their homeopathic nature, with a minimum of three letters and numbers for active ingredients and dosage strength.
Issues in medication safety.
The federal law requiring imprints on drugs is not meeting its intended purpose, as pharmacists and physicians struggle to reliably identify solid oral dosage forms with imprint codes.
DOI